CN115504862A - 一种大麻萜酚的制备方法 - Google Patents
一种大麻萜酚的制备方法 Download PDFInfo
- Publication number
- CN115504862A CN115504862A CN202110635009.XA CN202110635009A CN115504862A CN 115504862 A CN115504862 A CN 115504862A CN 202110635009 A CN202110635009 A CN 202110635009A CN 115504862 A CN115504862 A CN 115504862A
- Authority
- CN
- China
- Prior art keywords
- cannabigerol
- triflate
- preparation
- reaction
- geraniol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 title claims abstract description 40
- QXACEHWTBCFNSA-UHFFFAOYSA-N cannabigerol Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-UHFFFAOYSA-N 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims abstract description 32
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims abstract description 18
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims abstract description 18
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims abstract description 15
- 239000005792 Geraniol Substances 0.000 claims abstract description 15
- 229940113087 geraniol Drugs 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 14
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 13
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 14
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- 238000004440 column chromatography Methods 0.000 claims description 6
- 239000012044 organic layer Substances 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 4
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 claims description 4
- WLLIXJBWWFGEHT-UHFFFAOYSA-N [tert-butyl(dimethyl)silyl] trifluoromethanesulfonate Chemical compound CC(C)(C)[Si](C)(C)OS(=O)(=O)C(F)(F)F WLLIXJBWWFGEHT-UHFFFAOYSA-N 0.000 claims description 3
- UVECLJDRPFNRRQ-UHFFFAOYSA-N ethyl trifluoromethanesulfonate Chemical compound CCOS(=O)(=O)C(F)(F)F UVECLJDRPFNRRQ-UHFFFAOYSA-N 0.000 claims description 3
- OIRDBPQYVWXNSJ-UHFFFAOYSA-N methyl trifluoromethansulfonate Chemical compound COS(=O)(=O)C(F)(F)F OIRDBPQYVWXNSJ-UHFFFAOYSA-N 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 2
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 1
- 239000012295 chemical reaction liquid Substances 0.000 claims 1
- KHBAYPJBLAOMCF-UHFFFAOYSA-N hydroxy(trimethyl)silane trifluoromethanesulfonic acid Chemical compound C[Si](C)(C)O.OS(=O)(=O)C(F)(F)F KHBAYPJBLAOMCF-UHFFFAOYSA-N 0.000 claims 1
- 239000003054 catalyst Substances 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 3
- 238000003756 stirring Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 3
- 229930003827 cannabinoid Natural products 0.000 description 2
- 239000003557 cannabinoid Substances 0.000 description 2
- 229940065144 cannabinoids Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 240000004308 marijuana Species 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- IRMPFYJSHJGOPE-UHFFFAOYSA-N olivetol Chemical compound CCCCCC1=CC(O)=CC(O)=C1 IRMPFYJSHJGOPE-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 2
- 229930008411 3,7-dimethylocta-2,6-dien-1-ol Natural products 0.000 description 1
- SKZMHTRJUXJATN-UHFFFAOYSA-N 5-phenylpentane-1,3-diol Chemical compound OCCC(O)CCC1=CC=CC=C1 SKZMHTRJUXJATN-UHFFFAOYSA-N 0.000 description 1
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 1
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 description 1
- 229950011318 cannabidiol Drugs 0.000 description 1
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 description 1
- 229960004242 dronabinol Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0215—Sulfur-containing compounds
- B01J31/0222—Sulfur-containing compounds comprising sulfonyl groups
- B01J31/0224—Sulfur-containing compounds comprising sulfonyl groups being perfluorinated, i.e. comprising at least one perfluorinated moiety as substructure in case of polyfunctional compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0272—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing elements other than those covered by B01J31/0201 - B01J31/0255
- B01J31/0274—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing elements other than those covered by B01J31/0201 - B01J31/0255 containing silicon
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0272—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing elements other than those covered by B01J31/0201 - B01J31/0255
- B01J31/0275—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing elements other than those covered by B01J31/0201 - B01J31/0255 also containing elements or functional groups covered by B01J31/0201 - B01J31/0269
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
- B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
- B01J2231/4205—C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明公开了一种大麻萜酚的制备方法,以橄榄醇和香叶醇为原料,以三氟甲磺酸酯为催化剂,在溶剂中进行催化反应后得到大麻萜酚。本发明提供的大麻萜酚的制备方法条件温和、易于操作,最终获得大麻萜酚的收率较现有方法有明显提高,具有良好的应用前景。
Description
技术领域
本发明属于医药技术领域,尤其是涉及一种大麻萜酚的制备方法。
背景技术
大麻萜酚(CBG)是一种无精神活性和非成瘾性的大麻素类化合物并且具有抗炎、抗氧化、神经保护、缓解疼痛及抗肿瘤等多种药理活性。
CBG可以从工业大麻中提取获得。但是由于一般的工业大麻品种中,CBG 的含量很低,造成提取存在较大难度。再者,由于工业大麻中多种大麻素类化合物的性质非常接近,因此提取的CBG中会难以避免地存在少量大麻二酚、四氢大麻酚等,这对高纯度CBG的质量控制提出了极高的要求。
CBG也可以通过化学合成的方法获得,使用橄榄醇和香叶醇两种原料,在路易斯酸或质子酸的催化下生成CBG,技术路线如下所示:
如Baek等(Tetrahedron Lett.1985,26,1083)报道,将三氟化硼-乙醚吸附在硅胶上做催化剂,可将香叶醇和橄榄醇两种原料转化为大麻萜酚,收率是 29%。
近年来,也有一些专利文献(如WO2014134281A1,WO2017181118A1,WO2017216362A1)中使用对甲苯磺酸进行催化,大麻萜酚的收率有所提高,但仍然只能达到40%左右,且产生较多难以分离的杂质。
由此可见,现有CBG获取技术仍存在收率不高、产物难以分离的缺点,急需开发新的技术解决上述难题。
发明内容
发明目的:本发明的目的就是为了解决现有CBG制备方法收率低、产物难以分离的问题,而提供一种大麻萜酚的制备方法。
本发明的技术方案:
一种大麻萜酚的制备方法,以橄榄醇和香叶醇为原料,以三氟甲磺酸酯为催化剂,在三氟甲磺酸酯的催化下进行反应,制备得到大麻萜酚。
具体为:将橄榄醇和香叶醇溶解在溶剂中,再加入三氟甲磺酸酯进行催化反应,反应液经洗涤、浓缩后,可得大麻萜酚。
所述橄榄醇即3,5-二羟基戊苯,所述香叶醇即3,7-二甲基-2,6-辛二烯-1-醇。
进一步地,加入三氟甲磺酸酯时温度控制在-30~0℃,优选控制在 -25~-10℃。
进一步地,所述催化反应的温度为-40~60℃,反应时间为0.1~72小时;优选地,所述催化反应的温度为-20~30℃,反应时间为1~15小时;进一步优选地,所述催化反应的温度为20~25℃,反应时间为10~15小时。
进一步地,所述橄榄醇与香叶醇的摩尔比为1:0.5~10,所述三氟甲磺酸酯与橄榄醇的摩尔比为0.001~2:1。
优选地,所述橄榄醇与香叶醇的摩尔比为1:1~2,所述三氟甲磺酸酯与橄榄醇摩尔比为0.1~0.2:1。
进一步地,所述溶剂选自二氯甲烷、二氯乙烷、四氢呋喃、2-甲基四氢呋喃、丙酮、苯、甲苯、乙苯、二甲苯、氯苯、硝基苯、乙腈、N,N-二甲基甲酰胺、二甲基亚砜或乙酸乙酯中的一种或多种。
进一步地,所述三氟甲磺酸酯具有如下结构特征:CF3SO3R,其中R为 C1~C20的烃基或者-SiR1R2R3,所述R1、R2、R3各自独立地表示C1~C10的烃基,,所述C1~C20的烃基中的一个或多个-CH2-可被-O-替代;优选地,所述R 为-CH3或-Si(CH3)3。
进一步优选地,所述三氟甲磺酸酯选自三氟甲磺酸甲酯、三氟甲磺酸乙酯、三氟甲磺酸三甲基硅醇酯或叔丁基二甲硅基三氟甲磺酸酯中的一种或多种。
进一步地,反应结束后,依次以饱和碳酸氢钠、盐酸和饱和食盐水洗涤反应液,有机层减压浓缩后柱层析,得到大麻萜酚产品。
有益效果:
与现有技术相比,本发明使用三氟甲磺酸酯为催化剂,生成大麻萜酚的收率最低在50%以上,例如以三氟甲磺酸甲酯为催化剂时,生成大麻萜酚的收率高达65%,大大提高了制备效率,且产物仅需要简单的分离即可获得,有效解决了现有CBG制备方法收率低、产物难以分离的问题,具有显著的技术进步。
具体实施方式
下面结合具体实施例对本发明进行详细说明,但绝不是对本发明的限制。以下实施例中所采用的相关试剂均可以从市场购得。
实施例1
将18g(0.1mol)橄榄醇和23g(0.15mol)香叶醇溶解于100mL无水二氯甲烷中,降温至-20℃并向其中加入1.64g(0.01mol)三氟甲磺酸甲酯。在 -20℃下搅拌2小时,然后使反应液自然升至室温并继续搅拌12小时。停止反应后,依次用饱和碳酸氢钠、1M盐酸和饱和食盐水洗涤反应液。有机层减压浓缩后进行柱层析,得到白色固体20.6g,收率为65%。Mp 50~52℃;1H NMR (400MHz,DMSO-d6):δ8.91(s,2H),6.09(s,2H),5.17(s,1H),5.04(s,1H),3.12 (d,J=7.2Hz,2H),2.32(t,J=8.8Hz,2H),1.98(m,2H),1.88(m,2H),1.69(s, 3H),1.60(s,3H),1.52(s,3H),1.47(m,2H),1.26(m,4H),0.85(t,J=6.8Hz, 3H)。
实施例2
将18g(0.1mol)橄榄醇和23g(0.15mol)香叶醇溶解于100mL无水二氯甲烷中,降温至-20℃并向其中加入1.78g(0.01mol)三氟甲磺酸乙酯。在 -20℃下搅拌2小时,然后使反应液自然升至室温并继续搅拌12小时。停止反应后,依次用饱和碳酸氢钠、1M盐酸和饱和食盐水洗涤反应液。有机层减压浓缩后进行柱层析,得到白色固体18.36g,收率为58%。
实施例3
将18g(0.1mol)橄榄醇和27.77g(0.18mol)香叶醇溶解于100mL甲苯中,降温至-20℃并向其中加入4.44g(0.02mol)三氟甲磺酸三甲基硅醇酯。在-20℃下搅拌2小时,然后使反应液自然升至室温并继续搅拌20小时。停止反应后,依次用饱和碳酸氢钠、1M盐酸和饱和食盐水洗涤反应液。有机层减压浓缩后进行柱层析,得到白色固体17.41g,收率为55%。
实施例4
将18g(0.1mol)橄榄醇和27.77g(0.18mol)香叶醇溶解于100mL四氢呋喃中,降温至-20℃并向其中加入5.28g(0.02mol)叔丁基二甲硅基三氟甲磺酸酯。在-20℃下搅拌2小时,然后使反应液自然升至室温并继续搅拌12小时。停止反应后,依次以饱和碳酸氢钠、1M盐酸和饱和食盐水洗涤反应液。有机层减压浓缩后进行柱层析,得到白色固体16.46g,收率为52%。
由上述实施例可知,本发明使用三氟甲磺酸酯为催化剂,生成大麻萜酚的收率最低在52~65%以上,相比现有收率在29~40%左右,大麻萜酚的收率显著提高。
上述的对实施例的描述是为便于该技术领域的普通技术人员能理解和使用发明。熟悉本领域技术的人员显然可以容易地对这些实施例做出各种修改,并把在此说明的一般原理应用到其他实施例中而不必经过创造性的劳动。因此,本发明不限于上述实施例,本领域技术人员根据本发明的揭示,不脱离本发明范畴所做出的改进和修改都应该在本发明的保护范围之内。
Claims (10)
1.一种大麻萜酚的制备方法,其特征在于,将橄榄醇和香叶醇溶解在溶剂中,再加入三氟甲磺酸酯进行催化反应,反应液经后处理后,可得大麻萜酚。
2.根据权利要求1所述的大麻萜酚的制备方法,其特征在于,加入三氟甲磺酸酯时温度控制在-30~0℃,优选控制在-25~-10℃。
3.根据权利要求1所述的大麻萜酚的制备方法,其特征在于,所述催化反应的温度为-40~60℃,所述催化反应时间为0.1~72小时;优选地,所述催化反应的温度为-20~30℃,所述反应时间为1~15小时;进一步优选地,所述催化反应的温度为20~25℃,反应时间为10~15小时。
4.根据权利要求1所述的大麻萜酚的制备方法,其特征在于,所述橄榄醇与香叶醇的摩尔比为1:0.5~10,所述三氟甲磺酸酯与橄榄醇的摩尔比为0.001~2:1。
5.根据权利要求4所述的大麻萜酚的制备方法,其特征在于,所述橄榄醇与香叶醇的摩尔比为1:1~2,所述三氟甲磺酸酯与橄榄醇的摩尔比为0.1~0.2:1。
6.根据权利要求1所述的大麻萜酚的制备方法,其特征在于,所述溶剂选自二氯甲烷、二氯乙烷、四氢呋喃、2-甲基四氢呋喃、丙酮、苯、甲苯、乙苯、二甲苯、氯苯、硝基苯、乙腈、N,N-二甲基甲酰胺、二甲基亚砜或乙酸乙酯中的一种或多种。
7.根据权利要求1所述的大麻萜酚的制备方法,其特征在于,所述三氟甲磺酸酯具有如下结构特征:CF3SO3R,其中R为C1~C20的烃基或者-SiR1R2R3,所述R1、R2和R3各自独立地表示C1~C10的烃基,所述C1~C20的烃基中的一个或多个-CH2-可被-O-替代。
8.根据权利要求7所述的大麻萜酚的制备方法,其特征在于,所述R为-CH3或-Si(CH3)3。
9.根据权利要求7所述的大麻萜酚的制备方法,其特征在于,所述三氟甲磺酸酯选自三氟甲磺酸甲酯、三氟甲磺酸乙酯、三氟甲磺酸三甲基硅醇酯或叔丁基二甲硅基三氟甲磺酸酯中的一种或多种。
10.根据权利要求1所述的大麻萜酚的制备方法,其特征在于,反应结束后,依次以饱和碳酸氢钠、盐酸和饱和食盐水洗涤反应液,有机层减压浓缩后柱层析,得到大麻萜酚产品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110635009.XA CN115504862A (zh) | 2021-06-07 | 2021-06-07 | 一种大麻萜酚的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110635009.XA CN115504862A (zh) | 2021-06-07 | 2021-06-07 | 一种大麻萜酚的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115504862A true CN115504862A (zh) | 2022-12-23 |
Family
ID=84499900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110635009.XA Pending CN115504862A (zh) | 2021-06-07 | 2021-06-07 | 一种大麻萜酚的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115504862A (zh) |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5767256A (en) * | 1993-07-19 | 1998-06-16 | Hanessian; Stephen | Solution and solid phase stereocontrolled glycosidation |
WO2000059861A1 (en) * | 1999-04-06 | 2000-10-12 | Bristol-Myers Squibb Company | Selective retinoic acid analogs |
KR20070054217A (ko) * | 2004-09-24 | 2007-05-28 | 아스트라제네카 아베 | 화합물, 그를 함유하는 조성물, 그의 제조 방법 및 그의용도 |
US20080031977A1 (en) * | 2006-06-15 | 2008-02-07 | Gw Pharma Limited | Pharmaceutical compositions comprising cannabigerol |
CN102766190A (zh) * | 2012-08-05 | 2012-11-07 | 兰州大学 | 雷公藤内酯醇中间体不对称合成方法 |
CN105085275A (zh) * | 2014-08-29 | 2015-11-25 | 浙江工业大学 | 一种邻硝基苯酚类及其衍生物的合成方法 |
CN105622302A (zh) * | 2016-01-14 | 2016-06-01 | 常州大学 | 一种取代连苯三酚的合成方法 |
US20180362429A1 (en) * | 2016-08-16 | 2018-12-20 | Yunnan Hansu bio-technology Co., Ltd | Method for extracting cannabidiol from cannabis |
WO2020031179A1 (en) * | 2018-08-06 | 2020-02-13 | Beetlebung Pharma Ltd. | Methods for synthesis of cannabinoid compounds |
US20200115306A1 (en) * | 2018-10-10 | 2020-04-16 | Canopy Holdings, LLC | Synthesis of cannabigerol |
US20200354297A1 (en) * | 2019-05-10 | 2020-11-12 | Fresh Cut Development, Llc | Methods of Manufacturing Cannabidiol or Cannabidivarin and Intermediates of Manufacturing Cannabidiol or Cannabidivarin |
CN111943813A (zh) * | 2019-05-17 | 2020-11-17 | 上海特化医药科技有限公司 | 大麻二酚类化合物的制备方法 |
WO2021071908A1 (en) * | 2019-10-08 | 2021-04-15 | Berkowitz Barry A | Process for the production of cannabinoids and cannabinoid acids |
CN113226297A (zh) * | 2018-10-31 | 2021-08-06 | 海湾医学公司 | 大麻素类似物及其制备方法 |
WO2021195751A1 (en) * | 2020-03-31 | 2021-10-07 | Kare Chemical Technologies Inc. | Catalytic cannabigerol processes and precursors |
CA3132439A1 (en) * | 2020-05-12 | 2021-11-12 | Canopy Growth Corporation | Methods of synthesizing cannabigergol, cannabigerolic acid, and analogs thereof |
-
2021
- 2021-06-07 CN CN202110635009.XA patent/CN115504862A/zh active Pending
Patent Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5767256A (en) * | 1993-07-19 | 1998-06-16 | Hanessian; Stephen | Solution and solid phase stereocontrolled glycosidation |
WO2000059861A1 (en) * | 1999-04-06 | 2000-10-12 | Bristol-Myers Squibb Company | Selective retinoic acid analogs |
KR20070054217A (ko) * | 2004-09-24 | 2007-05-28 | 아스트라제네카 아베 | 화합물, 그를 함유하는 조성물, 그의 제조 방법 및 그의용도 |
US20080031977A1 (en) * | 2006-06-15 | 2008-02-07 | Gw Pharma Limited | Pharmaceutical compositions comprising cannabigerol |
CN102766190A (zh) * | 2012-08-05 | 2012-11-07 | 兰州大学 | 雷公藤内酯醇中间体不对称合成方法 |
CN105085275A (zh) * | 2014-08-29 | 2015-11-25 | 浙江工业大学 | 一种邻硝基苯酚类及其衍生物的合成方法 |
CN105622302A (zh) * | 2016-01-14 | 2016-06-01 | 常州大学 | 一种取代连苯三酚的合成方法 |
US20180362429A1 (en) * | 2016-08-16 | 2018-12-20 | Yunnan Hansu bio-technology Co., Ltd | Method for extracting cannabidiol from cannabis |
WO2020031179A1 (en) * | 2018-08-06 | 2020-02-13 | Beetlebung Pharma Ltd. | Methods for synthesis of cannabinoid compounds |
US20200115306A1 (en) * | 2018-10-10 | 2020-04-16 | Canopy Holdings, LLC | Synthesis of cannabigerol |
CN113226297A (zh) * | 2018-10-31 | 2021-08-06 | 海湾医学公司 | 大麻素类似物及其制备方法 |
US20200354297A1 (en) * | 2019-05-10 | 2020-11-12 | Fresh Cut Development, Llc | Methods of Manufacturing Cannabidiol or Cannabidivarin and Intermediates of Manufacturing Cannabidiol or Cannabidivarin |
CN111943813A (zh) * | 2019-05-17 | 2020-11-17 | 上海特化医药科技有限公司 | 大麻二酚类化合物的制备方法 |
WO2021071908A1 (en) * | 2019-10-08 | 2021-04-15 | Berkowitz Barry A | Process for the production of cannabinoids and cannabinoid acids |
WO2021195751A1 (en) * | 2020-03-31 | 2021-10-07 | Kare Chemical Technologies Inc. | Catalytic cannabigerol processes and precursors |
CA3174197A1 (en) * | 2020-03-31 | 2021-10-07 | Kamaluddin Abdur-Rashid | Catalytic cannabigerol processes and precursors |
CA3132439A1 (en) * | 2020-05-12 | 2021-11-12 | Canopy Growth Corporation | Methods of synthesizing cannabigergol, cannabigerolic acid, and analogs thereof |
US20220024843A1 (en) * | 2020-05-12 | 2022-01-27 | Canopy Growth Corporation | Methods of synthesizing cannabigergol, cannabigerolic acid, and analogs thereof |
Non-Patent Citations (4)
Title |
---|
LIU Y,等: "MeOTf-catalyzed annulation of aldehydes and aryalkynes leading to 2, 3-disubstituted indanones", ORGANIC CHEMISTRY FRONTIERS, vol. 3, no. 9, pages 1116 - 1119 * |
NICHOLAS G. JENTSCH,等: "Efficient Synthesis of Cannabigerol, Grifolin, and Piperogalin via Alumina-Promoted Allylation", JOURNAL OF NATURAL PRODUCT, vol. 83, pages 2587 - 2588 * |
刘宇,等: "三氟甲磺酸金属盐催化构建碳-碳键反应的研究", 中国化学会第30届学术年会摘要集-第九分会:有机化学, pages 1 * |
尹显洪: "固体超强酸催化合成乙酸橙花酯和乙酸香叶酯", 精细化工, no. 11, pages 641 - 644 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107879962B (zh) | 一种格隆溴铵的制备方法 | |
CN114349674B (zh) | 一种硫脲类化合物及其制备方法 | |
CN115504862A (zh) | 一种大麻萜酚的制备方法 | |
CN102336798A (zh) | 人参皂苷Rh3的合成方法 | |
CN111662263B (zh) | 一种吡喃酮化合物的制备方法 | |
CN114516817B (zh) | 一种化工中间体及制备方法 | |
CN113999167B (zh) | 一种4-氯-2,6-二甲基-3-硝基吡啶的制备方法 | |
CN113024375B (zh) | 一种反,反-4-烷基-4′-戊基-3(e)烯-双环己烷类液晶单体的制备方法 | |
CN117402104A (zh) | 阿伐可泮手性中间体的制备方法 | |
CN112679512B (zh) | 曲贝替定中间体及其制备方法 | |
CN110734354B (zh) | 一种由醇类化合物制备联芳烃类化合物的方法 | |
CN111100042B (zh) | 一种2-甲氧基-5-磺酰胺基苯甲酸的制备方法 | |
CN114591148A (zh) | 一种基于微反应器合成双酚芴的方法 | |
KR101769204B1 (ko) | 크로마놀 유도체의 신규한 제조방법 | |
CN111072450B (zh) | 一种烯丙醇类衍生物的合成方法 | |
CN108558803B (zh) | 一种n-取代苯酐-(s)-异丝氨酸的合成方法 | |
CN111825688B (zh) | 一种6-叔丁基-3’,3’,3-三甲基吡喃[3,2-a]咔唑的制备方法 | |
CN107501159B (zh) | 维拉佐酮中间体3-(4-氯丁基)-5-氰基吲哚合成方法 | |
CN111087340B (zh) | 一种维拉佐酮中间体的制备方法 | |
CN109593090A (zh) | 一种恩替卡韦的合成方法 | |
CN115850029B (zh) | 一种2,4-二枯基酚的合成方法 | |
CN112939920B (zh) | 一种龙血竭红素a或龙血竭红素b的制备方法 | |
KR102632488B1 (ko) | 연속 흐름 화학에 의한 bbmo의 합성 방법 | |
CN111825641B (zh) | 一种制备3-氟-4-羟基-5-(羟基甲基)-3-甲基四氢呋喃-2-酮的方法 | |
CN114957178B (zh) | 一种3-卤代-1-羟基二苯并呋喃化合物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |